Trials / Completed
CompletedNCT00746005
Efficacy of Fish Oil Supplementation on Cognition in MCI Patients and the Influence of the APOE4 Allele
Challenge Study: The Efficacy of Fish Oil Supplementation on Cognitive Performance in MCI Patients and the Influence of the APOE-epsilon4 Allele
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Wageningen University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To study the short term effects of a pharmacological dose of fish oil on cognitive performance and on cerebral blood flow. Furthermore, we want to investigate whether carriers of the APOEε4 allele respond differently to fish oil treatment compared to non-carriers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | fish oil | 3 g fish oil (3078 mg) total EPA 1512 mg and total DHA 1026 mg |
| DIETARY_SUPPLEMENT | placebo, sunflower oil | 3 g of sunflower oil |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2008-09-03
- Last updated
- 2011-01-12
Locations
2 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00746005. Inclusion in this directory is not an endorsement.